The global dental biomaterials market is poised for robust growth in the coming years. In 2021, the market was valued at US$ 6.6 billion, and by 2031, it is projected to reach a staggering US$ 13.0 billion, exhibiting a CAGR of 6.8% from 2022 to 2031. This growth is driven by a confluence of factors, including advancements in materials science and technology, increasing demand for cosmetic dentistry procedures, and a growing global awareness of oral health.
The emergence of biocompatible materials and advanced techniques has paved the way for a wider application of biomaterials in dentistry. The development of novel materials, such as luting cements, dentin bonding agents, glass ionomers, and composites, has spurred the need for a multidisciplinary approach to achieve superior biologic performance and biocompatibility. This has further fueled the growth of the dental biomaterials market.
Bone graft materials are expected to dominate the market during the forecast period. These materials are essential for dental restorations, bone growth, and implant fixtures. The implantology segment, which encompasses the use of dental implants, is projected to hold a substantial share of the global market in 2021. Dental clinics are also expected to play a significant role in the market, as they are the primary point of contact for dental procedures.
Regional Landscape
Europe is expected to account for the majority of sales during the forecast period, driven by its stringent regulations on dental biomaterials. The emphasis on safety and quality within the region has resulted in a robust market for advanced and biocompatible materials. Moreover, Europe is home to numerous dental technology startups, universities, and research organizations that are continually advancing the field. The region’s robust healthcare infrastructure, coupled with increasing investments in dental care facilities and equipment, is further bolstering the market.
Asia Pacific is projected to experience rapid growth in the coming years, fueled by rising disposable incomes, growing awareness of oral health, and a burgeoning middle class.
Key Drivers of Market Growth
*
Advancements in Materials Science and Technology:
The development of novel biomaterials with enhanced longevity, biocompatibility, and aesthetics has expanded the scope of dental procedures and treatments, driving the demand for these materials.*
Rise of Cosmetic Dentistry:
Cosmetic dentistry procedures, such as dental bonding, veneers, teeth whitening, and dental implants, are becoming increasingly popular due to their long-lasting and natural-looking results. Dental biomaterials play a crucial role in these procedures, contributing to their success.*
Prevalence of Dental Problems:
Tooth loss, gum disease, and dental cavities are prevalent worldwide, leading to a greater demand for restorative and reconstructive dental procedures. Biomaterials play a critical role in these procedures, further bolstering the market.*
Government Investments in Healthcare:
Investments in dental infrastructure and healthcare spending are increasing in emerging nations, driving growth in the dental biomaterials market. This translates into increased demand for dental materials as investments are made in dental clinics, teaching facilities, and research.*
Consumer Acceptability:
Consumers are increasingly aware of the importance of oral health and are embracing cutting-edge dental treatments. This growing acceptance has resulted in a higher demand for dental biomaterials, particularly those offering comfort, durability, and aesthetics.Competitive Landscape
Several key players in the global dental biomaterials market are expanding their product portfolios and strengthening their geographical reach through strategic acquisitions, mergers, and new product launches. Some of the key players in the market include:
* Geistlich Pharma AG
* Henry Schein Inc.
* 3M
* Zimmer Biomet
* Dentsply Sirona
* Institut Straumann AG
* BioHorizons IPH, Inc.
* Danaher Corporation (Nobel Biocare Services AG)
* ACE Surgical Supply Company Inc.
* Biomatlante
Key Developments:
* In October 2022, Geistlich Pharma North America acquired Lynch Biologics, LLC, a company specializing in oral regeneration products. This acquisition strengthened Geistlich’s regenerative product portfolio and significantly increased its growth potential.
* In December 2022, Henry Schein acquired a majority stake in Biotech Dental, expanding its product and service offerings. This deal will give the US dental giant access to dental implants, clinical software, and a range of oral surgery and orthodontics products.
The dental biomaterials market is expected to witness continued growth in the coming years, driven by advancements in materials science, increasing demand for cosmetic dentistry, and a growing global emphasis on oral health. With the increasing adoption of innovative biomaterials and technologies, the market is poised to achieve significant milestones in the years to come.
